A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening - Full Text View

Purpose

RATIONALE: Screening may help doctors find breast cancer cells early and plan better treatment for breast cancer. The Mammography FastTrack program may be effective in increasing the number of patients who undergo mammography.

PURPOSE: This randomized clinical trial is studying the use of a Mammography FastTrack program to increase the number of women who undergo mammography.

Condition	Intervention
Breast Cancer	Other: counseling intervention Other: educational intervention Procedure: radiomammography

Study Type:	Interventional
Study Design:	Allocation: Randomized Primary Purpose: Health Services Research
Official Title:	Breast Cancer Screening and Follow-Up in a PBRN: The Mammography FastTrack Trial

Resource links provided by NLM:

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer Mammography

U.S. FDA Resources

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Difference in percentage of patients overdue at baseline receiving mammogram during the study period in intervention and control practices [ Designated as safety issue: No ]

Secondary Outcome Measures:

Difference in percentage of patients overdue at baseline receiving mammogram during the study period in intervention and control practices at 6 months [ Designated as safety issue: No ]
Comparison of time to mammography completion in intervention vs control groups [ Designated as safety issue: No ]
Clinical and nonclinical outcomes recorded by Mammography FastTrack tool [ Designated as safety issue: No ]

Estimated Enrollment:	6730
Study Start Date:	March 2007
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)

Detailed Description:

OBJECTIVES:

Classify all patients within the Massachusetts General Primary Care-Practice Based Research Network (MGPC-PBRN) according to patient-primary care provider (PCP) linkage status.
Develop a breast cancer screening intervention program called Mammography FastTrack that facilitates the ordering of mammograms to be used either by PCPs (for PCP-linked patients) or by practice managers (for practice-linked patients).
Compare the impact of the Mammography FastTrack program on mammography screening rates in PCP-linked vs practice-linked patients overdue for breast cancer screening.

OUTLINE: This is a randomized, multicenter study.

Mammography-eligible women are linked to either a provider or a practice within the Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN). Practices within the MGPC-PBRN are stratified according to baseline mammography screening rates (high vs low) and practice type (community health center vs hospital-based vs community-based) and are randomized to 1 of 2 arms.

Arm I: Physicians and practice managers receive e-mail alerts at months 1 and 3 informing them of the availability of mammography screening data for their panel of primary-care patients. A hyperlink refers the provider to a web-portal for the Mammography FastTrack program that lists all eligible patients who have not undergone mammography. The provider may then click a button to schedule, defer (providing reason for deferral), or provide the date of a recent mammogram.
Arm II: Practices continue standard care. At the end of 12 months, electronic report and billing data and a review of electronic health records are used to determine the completion of mammograms.

PROJECTED ACCRUAL: A total of 6,730 patients will be accrued for this study.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

DISEASE CHARACTERISTICS:

Any outpatient at a participating Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN) practice within the past 3 years
- No patient who the Massachusetts General Hospital system lists as having a primary care provider who is not in one of the MGPC-PBRN networks (linking patients with a provider or practice)
- No patient who is not linked to specific provider or practice (randomized portion of study)
Billing, scheduling, and clinical electronic data sources required
No mammogram within the past 2 years (randomized portion of study)
Hormone receptor status not specified

PATIENT CHARACTERISTICS:

Age 42 to 69 years (randomized portion of study)
Female
Menopausal status not specified

PRIOR CONCURRENT THERAPY:

No prior bilateral mastectomy (randomized portion of study)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00462891

Locations

United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114

Sponsors and Collaborators

Massachusetts General Hospital

National Cancer Institute (NCI)

Investigators

Study Chair:

Michael J. Barry, MD

Massachusetts General Hospital

More Information

Publications:

Atlas SJ, Grant RW, Lester WT, Ashburner JM, Chang Y, Barry MJ, Chueh HC. A cluster-randomized trial of a primary care informatics-based system for breast cancer screening. J Gen Intern Med. 2011 Feb;26(2):154-61. Epub 2010 Sep 15.

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Atlas SJ, Ashburner JM, Chang Y, Lester WT, Barry MJ, Grant RW. Population-based breast cancer screening in a primary care network. Am J Manag Care. 2012 Dec;18(12):821-9.

ClinicalTrials.gov Identifier:	NCT00462891 History of Changes
Other Study ID Numbers:	CDR0000539006, MGH-2005-P-002474/1
Study First Received:	April 18, 2007
Last Updated:	November 15, 2011
Health Authority:	United States: Federal Government

Keywords provided by National Cancer Institute (NCI):

breast cancer

Additional relevant MeSH terms:

Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 19, 2013